BioFund Management
11
10M
9
0.44
4
0.18
3
- Stages of investment
- Areas of investment
Summary
In 1997 was created BioFund Management, which is appeared as VC. The venture was found in Europe in Finland. The leading representative office of defined VC is situated in the Helsinki.
The typical case for the fund is to invest in rounds with 3-4 participants. Despite the BioFund Management, startups are often financed by HBM Healthcare Investments AG, MVI Finance, Biotech Turnaround Fund (BTF). The meaningful sponsors for the fund in investment in the same round are HBM Healthcare Investments AG, Sitra, MVI Finance. In the next rounds fund is usually obtained by HBM Healthcare Investments AG, Index Ventures, Biofund.
The fund was created by Kalevi Kurkiju00e4rvi. The overall number of key employees were 2.
The usual things for fund are deals in the range of 10 - 50 millions dollars. Speaking about the real fund results, this VC is 13 percentage points more often commits exit comparing to other organizations. The top amount of exits for fund were in 2014. Opposing the other organizations, this BioFund Management works on 13 percentage points more the average amount of lead investments. The high activity for fund was in 2005. The fund is generally included in less than 2 deals every year.
The fund has exact preference in a number of founders of portfolio startups. For fund there is no match between the location of its establishment and the land of its numerous investments - United States. We can highlight the next thriving fund investment areas, such as Medical, Health Care. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight FibroGen, Genizon BioSciences, FIT Biotech.
Investments analytics
Analytics
- Total investments
- 11
- Lead investments
- 4
- Exits
- 3
- Rounds per year
- 0.44
- Follow on index
- 0.18
- Investments by industry
- Biotechnology (10)
- Genetics (5)
- Life Science (4)
- Medical Device (4)
- Health Diagnostics (2) Show 8 more
- Investments by region
-
- Canada (4)
- Finland (3)
- United States (1)
- Switzerland (1)
- Sweden (1) Show 1 more
- Peak activity year
- 2005
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 22
- Group Appearance index
- 0.91
- Avg. company exit year
- 12
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Ipsat Therapies | 03 Apr 2005 | Biotechnology, Health Diagnostics, Therapeutics | Late Stage Venture | 9M | Finland, Uusimaa, Helsinki |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.